Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_assertion type Assertion NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_head.
- NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_assertion description "[Thirty-two rectal cancer subjects had paired preneoadjuvant and postneoadjuvant tissue available for IHC staining (MLH1, MSH2, MSH6, and PMS2), whereas 39 rectosigmoid cancer patients who did not receive neoadjuvant treatment served as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_provenance.
- NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_assertion evidence source_evidence_literature NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_provenance.
- NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_assertion SIO_000772 25150747 NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_provenance.
- NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_assertion wasDerivedFrom befree-2016 NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_provenance.
- NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_assertion wasGeneratedBy ECO_0000203 NP1213097.RAUA7qsPZUUxxvGbqpoX9p9EOeTa3VWfkuELm4c-ghVbk130_provenance.